GUM disease has been linked to
a greater rate of cognitive decline
in people with Alzheimer’s Disease
(AD), early stage research published
in PLOS One, and reported first by
BBC News, has indicated.
The study, involving 59 people
with mild to moderate dementia
investigated over a six month
period, was suggestive that
the body’s response to gum
inflammation may be hastening the
brain’s decline by up to six-fold.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.